세계의 골내 장치 시장 : 시장 규모(유형별, 최종사용자별, 지역별), 예측

Intraosseous Devices Market Size And Forecast

Intraosseous Devices Market size was valued at USD 412.82 Million in 2024 and is projected to reach USD 592.94 Million by 2032, growing at a CAGR of 4.63% from 2026 to 2032.

The high prevalence of various diseases, such as cardiac arrest, emergencies including trauma, and increasing military engagements are expected to fuel the growth of the global Intraosseous Devices Market. Growth in the number of government and regulatory approvals is proving to be the foundation for the Intraosseous Devices Market. In addition, the increasing research and development activities as well as the increased awareness about public health is driving the market growth. The Global Intraosseous Devices Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Intraosseous Devices Market Definition

Intraosseous devices are emergency medical equipment used for dealing with life-threatening conditions. Intraosseous devices can be used to supply medications and vital fluids in an emergency when venous access is absent. Intraosseous vascular is an alternative method for immediate medical intervention during emergency conditions. The device is quickly inserted into the medullary space of bone and accurate positioning of the device is indicated by the flow of intravenous fluid into the device.

If extravasation of the fluid around the insertion area occurs, the device is removed to prevent the growth of compartment syndrome. However, aspiration of bone marrow signifies another method to confirm the correct positioning of the device. Intraosseous devices are quick, easy, and effective. This device infuses medication directly into systemic circulation via bone marrow and is useful in emergency and delayed situations. These devices are used in the treatment of hematology/oncology patients, traumas, cardiac arrest, and diabetic patients.

Global Intraosseous Devices Market Overview

The increasing number of injuries, along with the failure of intravenous vascular access, is expected to fuel the market for intraosseous devices in the immediate future. Intraosseous infusion is a secure and efficient technology for cardiopulmonary resuscitation where other routes of administration struggle to achieve the desired impact.

The high prevalence of multiple diseases such as cardiac arrest, emergencies such as trauma, and rising military engagements are driving the global Intraosseous Devices Market. The increasing per capita income and a growing willingness to invest in advanced care are also fueling demand. Intraosseous infusion is most often used in pediatric pre-hospital emergencies where intravenous administration of fluids and medications is impossible. The rising prevalence of multiple disease types, as well as the number of traumatic surgeries, are likely to drive demand for these devices in the coming years.

The risks such as fractures during insertion, extravasation of drugs being managed, infections at the insertion site, as well as high medication costs, a shortage of medical expertise for nurses, and poor equipment management, are potential factors restraining the Intraosseous Devices Market. The rising regulatory approvals, mergers and acquisitions, and new markets created by developing economies present favorable growth opportunities in the market.

Global Intraosseous Devices Market Segmentation Analysis

The Global Intraosseous Devices Market is Segmented on the basis of Type, End-User, And Geography.

Intraosseous Devices Market, By Type

• Manual
• Semi-Automatic
• Automatic

Based on Type, The market is segmented into Manual, Semi-Automatic, and Automatic. The automatic and semi-automatic segments are projected to grow because they are more technologically advanced than the manual.

Intraosseous Devices Market, By End-User

• Hospitals
• Emergency Medical Services (EMS)
• Military
• Others

Based on End-User, The market is segmented into Hospitals, Emergency Medical Services (EMS), Military, and Others. Due to the increased number of emergency situations, expanding medical personnel and specialized personnel, and growing patient population cases, the EMS segment is projected to lead the global Intraosseous Devices Market.

Intraosseous Devices Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world
• On the basis of Geography, The Global Intraosseous Devices Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America has the strongest market share and is expected to grow in the coming years. The demand in North America is primarily led by an increase in the number of emergency cases, cardiac cases, and multiple diseases requiring immediate vascular access, as well as an increase in the acceptance of advanced products, a large number of medical practitioners, and specialized personnel, and the involvement of prominent players in these regions.

Key Players

The "Global Intraosseous Devices Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Teleflex Incorporated, PERSYS MEDICAL, Cook, BD, Biopsybell, Pyng Medical Corp., Aero Healthcare, Vidacare Corporation, Carefusion Inc., and Others. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

Key Developments

• Mergers and Acquisitions
• In December 2013, Teleflex Incorporated acquired Vidacare Corporation, a provider of intraosseous, or into the bone, access devices. This acquisition complemented the vascular access and specialty product portfolio of the company's critical care product group.
• Product Launches and Product Expansions
• In March 2020, SAM Medical launched SAM IO Intraosseous Access System for pre-hospital and hospital healthcare providers in the civilian and military sectors.
• In November 2019, Piper Access, LLC received FDA 510(k) clearance for Piper Go-IO Intraosseous Infusion System from Piper Access.
• In May 2018, TraumaFX, a division of Kforce Government Solutions, Inc. and a global provider of ruggedized human and canine medical training simulators, launched K9 Diesel, a canine medical simulator.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL INTRAOSSEOUS DEVICES MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL INTRAOSSEOUS DEVICES MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.2 Porters Five Force Model
• 4.3 Value Chain Analysis

5 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY TYPE

• 5.1 Overview
• 5.2 Manual
• 5.3 Semi-Automatic
• 5.4 Automatic

6 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY END-USER

• 6.1 Overview
• 6.2 Hospitals
• 6.3 Emergency Medical Services (EMS)
• 6.4 Military
• 6.5 Others

7 GLOBAL INTRAOSSEOUS DEVICES MARKET, BY GEOGRAPHY

• 7.1 Overview
• 7.2 North America
  • 7.2.1 U.S.
  • 7.2.2 Canada
  • 7.2.3 Mexico
• 7.3 Europe
  • 7.3.1 Germany
  • 7.3.2 U.K.
  • 7.3.3 France
  • 7.3.4 Rest of Europe
• 7.4 Asia Pacific
  • 7.4.1 China
  • 7.4.2 Japan
  • 7.4.3 India
  • 7.4.4 Rest of Asia Pacific
• 7.5 Rest of the World
  • 7.5.1 Latin America
  • 7.5.2 Middle East & Africa

8 GLOBAL INTRAOSSEOUS DEVICES MARKET COMPETITIVE LANDSCAPE

• 8.1 Overview
• 8.2 Company Market ranking
• 8.3 Key Development Strategies

9 COMPANY PROFILES

• 9.1 Teleflex Incorporated
  • 9.1.1 Overview
  • 9.1.2 Financial Performance
  • 9.1.3 Product Outlook
  • 9.1.4 Key Developments
• 9.2 PERSYS MEDICAL
  • 9.2.1 Overview
  • 9.2.2 Financial Performance
  • 9.2.3 Product Outlook
  • 9.2.4 Key Developments
• 9.3 Cook
  • 9.3.1 Overview
  • 9.3.2 Financial Performance
  • 9.3.3 Product Outlook
  • 9.3.4 Key Developments
• 9.4 BD
  • 9.4.1 Overview
  • 9.4.2 Financial Performance
  • 9.4.3 Product Outlook
  • 9.4.4 Key Developments
• 9.5 Biopsybell
  • 9.5.1 Overview
  • 9.5.2 Financial Performance
  • 9.5.3 Product Outlook
  • 9.5.4 Key Developments
• 9.6 Pyng Medical Corp.
  • 9.6.1 Overview
  • 9.6.2 Financial Performance
  • 9.6.3 Product Outlook
  • 9.6.4 Key Developments
• 9.7 Aero Healthcare
  • 9.7.1 Overview
  • 9.7.2 Financial Performance
  • 9.7.3 Product Outlook
  • 9.7.4 Key Developments
• 9.8 Vidacare Corporation
  • 9.8.1 Overview
  • 9.8.2 Financial Performance
  • 9.8.3 Product Outlook
  • 9.8.4 Key Developments
• 9.9 Carefusion Inc.
  • 9.9.1 Overview
  • 9.9.2 Financial Performance
  • 9.9.3 Product Outlook
  • 9.9.4 Key Developments

10 APPENDIX

• 10.1 Related Research